Grass Pollen Allergy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Grass pollen allergy is a reaction which occurs soon after exposure to pollen from grasses. Signs and symptoms include skin reactions, such as hives, redness or swelling, itching or tingling in or around the mouth and throat, tightening of the throat, shortness of breath or wheezing and runny nose. Predisposing factors include age, family history and other allergies.
The Grass pollen allergy – Drugs in Development research report provides a comprehensive overview on the therapeutics under development for Grass pollen allergy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Grass pollen allergy and features dormant and discontinued projects.
Key Targets in the Grass Pollen Allergy Pipeline Drugs Market
The key targets in the Grass Pollen Allergy pipeline drugs market are Interleukin 4 Receptor Subunit Alpha, and Pituitary Adenylate Cyclase Activating Polypeptide.
Grass Pollen Allergy Drugs Market, by Targets
For more target insights, download a free report sample
Key MoA in the Grass Pollen Allergy Pipeline Drugs Market
The key mechanisms of action in the Grass Pollen Allergy pipeline drugs market are Interleukin 4 Receptor Subunit Alpha Antagonist, and Pituitary Adenylate Cyclase Activating Polypeptide Inhibitor.
Grass Pollen Allergy Pipeline Drugs Market, by MoA
To get more insights on key MoA, download a free sample report
Grass Pollen Allergy Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Grass Pollen Allergy pipeline drugs market are Subcutaneous, Intravenous, Oral, and Sublingual.
Grass Pollen Allergy Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Grass Pollen Allergy Pipeline Drugs Market
The key molecule types in the Grass Pollen Allergy pipeline drugs market are Allergenics (Allergen), Monoclonal Antibody, Conjugate Vaccine, Peptide, Synthetic Peptide, and Vaccine.
Grass Pollen Allergy Pipeline Drugs Market, by Molecule Type
To get more insights on key molecule types, download a free sample report
Major Companies in the Grass Pollen Allergy Pipeline Drugs Market
The major companies in the Grass Pollen Allergy pipeline drugs market are Allergy Therapeutics Plc, ASIT Biotech SA, DC4U BV, H. Lundbeck AS, HAL Allergy BV, Regeneron Pharmaceuticals Inc, Revolo Biotherapeutics Ltd, Roxall Medizin GmbH, and Worg Pharmaceuticals Hangzhou Co Ltd.
Grass Pollen Allergy Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Grass Pollen Allergy Pipeline Drugs Market Overview
Key Targets | Interleukin 4 Receptor Subunit Alpha, and Pituitary Adenylate Cyclase Activating Polypeptide |
Key Mechanisms of action | Interleukin 4 Receptor Subunit Alpha Antagonist, and Pituitary Adenylate Cyclase Activating Polypeptide Inhibitor |
Key Routes of Administration | Subcutaneous, Intravenous, Oral, and Sublingual |
Key Molecule Types | Allergenics (Allergen), Monoclonal Antibody, Conjugate Vaccine, Peptide, Synthetic Peptide, and Vaccine |
Major Companies | Allergy Therapeutics Plc, ASIT Biotech SA, DC4U BV, H. Lundbeck AS, HAL Allergy BV, Regeneron Pharmaceuticals Inc, Revolo Biotherapeutics Ltd, Roxall Medizin GmbH, and Worg Pharmaceuticals Hangzhou Co Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Grass Pollen Allergy
- The pipeline guide reviews pipeline therapeutics for Grass Pollen Allergy by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Grass Pollen Allergy therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Grass Pollen Allergy therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Grass Pollen Allergy
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Grass Pollen Allergy
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Grass Pollen Allergy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
ASIT Biotech SA
DC4U BV
H. Lundbeck AS
HAL Allergy BV
Regeneron Pharmaceuticals Inc
Revolo Biotherapeutics Ltd
Roxall Medizin GmbH
Worg Pharmaceuticals Hangzhou Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Grass Pollen Allergy pipeline drugs market?
The key targets in the Grass Pollen Allergy pipeline drugs market are Interleukin 4 Receptor Subunit Alpha, and Pituitary Adenylate Cyclase Activating Polypeptide.
-
What are the key mechanisms of action in the Grass Pollen Allergy pipeline drugs market?
The key mechanisms of action in the Grass Pollen Allergy pipeline drugs market are Interleukin 4 Receptor Subunit Alpha Antagonist, and Pituitary Adenylate Cyclase Activating Polypeptide Inhibitor.
-
What are the key routes of administration in the Grass Pollen Allergy pipeline drugs market?
The key routes of administration in the Grass Pollen Allergy pipeline drugs market are Subcutaneous, Intravenous, Oral, and Sublingual.
-
What are the key molecule types in the Grass Pollen Allergy pipeline drugs market?
The key molecule types in the Grass Pollen Allergy pipeline drugs market are Allergenics (Allergen), Monoclonal Antibody, Conjugate Vaccine, Peptide, Synthetic Peptide, and Vaccine.
-
What are the major companies in the Grass Pollen Allergy pipeline drugs market?
The major companies in the Grass Pollen Allergy pipeline drugs market are Allergy Therapeutics Plc, ASIT Biotech SA, DC4U BV, H. Lundbeck AS, HAL Allergy BV, Regeneron Pharmaceuticals Inc, Revolo Biotherapeutics Ltd, Roxall Medizin GmbH, and Worg Pharmaceuticals Hangzhou Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.